179 related articles for article (PubMed ID: 25267750)
61. Sunitinib-induced hand-foot syndrome in a renal cell carcinoma: a sclerodermatous and rheumatoid arthritis-like case.
Ohtsuka T
J Dermatol; 2012 Nov; 39(11):943-4. PubMed ID: 22257303
[No Abstract] [Full Text] [Related]
62. Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies.
Alexandrescu DT; Popoveniuc G; Farzanmehr H; Dasanu CA; Dawson N; Wartofsky L
Thyroid; 2008 Jul; 18(7):809-12. PubMed ID: 18631016
[No Abstract] [Full Text] [Related]
63. Kidney cancer: TKIs associated with stroke risk.
Fenner A
Nat Rev Urol; 2015 Nov; 12(11):597. PubMed ID: 26502989
[No Abstract] [Full Text] [Related]
64. Fatal liver failure in a patient treated with sunitinib for renal cell carcinoma.
Mermershtain W; Lazarev I; Shani-Shrem N; Ariad S
Clin Genitourin Cancer; 2013 Mar; 11(1):70-2. PubMed ID: 23063577
[No Abstract] [Full Text] [Related]
65. [Treatment with sunitinib and hypothyroidism--a case report and overview of literature].
Kreze A; Stáhalová V; Zadrazilová A; Koskuba J; Kosák M
Klin Onkol; 2009; 22(4):176-8. PubMed ID: 19731880
[TBL] [Abstract][Full Text] [Related]
66. Sunitinib and hypothyroidism.
Wolter P; Dumez H; Schöffski P
N Engl J Med; 2007 Apr; 356(15):1580; author reply 1580-1. PubMed ID: 17429091
[No Abstract] [Full Text] [Related]
67. Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials.
Santoni M; Conti A; Massari F; Arnaldi G; Iacovelli R; Rizzo M; De Giorgi U; Trementino L; Procopio G; Tortora G; Cascinu S
Int J Cancer; 2015 Jan; 136(1):1-10. PubMed ID: 24415642
[TBL] [Abstract][Full Text] [Related]
68. Subacute cutaneous lupus erythematosus induced by the new multikinase inhibitor pazopanib.
Casado-Verrier B; Pérez-Santos S; Delgado-Mucientes C; Beato-Merino M
Br J Dermatol; 2014 Dec; 171(6):1559-61. PubMed ID: 24909204
[No Abstract] [Full Text] [Related]
69. Systemic treatment options for untreated patients with metastatic clear cell renal cancer.
Molina AM; Motzer RJ; Heng DY
Semin Oncol; 2013 Aug; 40(4):436-43. PubMed ID: 23972707
[TBL] [Abstract][Full Text] [Related]
70. Severe cardiomyopathy in a patient with renal cell carcinoma after treatment with the novel tyrosine kinase inhibitor sunitinib.
Chorianopoulos E; Jäger D; Katus HA; Frey N
Clin Res Cardiol; 2007 Nov; 96(11):829-30. PubMed ID: 17694380
[No Abstract] [Full Text] [Related]
71. Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate.
Nicholaou T; Wong R; Davis ID
Lancet; 2007 Jun; 369(9577):1923-4. PubMed ID: 17560435
[No Abstract] [Full Text] [Related]
72. Pazopanib versus sunitinib in renal cancer.
Casper J; Schumann-Binarsch S; Köhne CH
N Engl J Med; 2013 Nov; 369(20):1969. PubMed ID: 24224638
[No Abstract] [Full Text] [Related]
73. Pazopanib versus sunitinib in renal cancer.
Wittes J
N Engl J Med; 2013 Nov; 369(20):1969. PubMed ID: 24224637
[No Abstract] [Full Text] [Related]
74. Pazopanib versus sunitinib in renal cancer.
Ramaekers R; Tharnish M; Copur MS
N Engl J Med; 2013 Nov; 369(20):1968-9. PubMed ID: 24224636
[No Abstract] [Full Text] [Related]
75. Pazopanib versus sunitinib in renal cancer.
Motzer RJ; McCann L; Deen K
N Engl J Med; 2013 Nov; 369(20):1970. PubMed ID: 24224635
[No Abstract] [Full Text] [Related]
76. Pazopanib- and bevacizumab-induced reversible heart failure in a patient with metastatic renal cell carcinoma: A case report.
Abdallah AO; Vallurupalli S; Kunthur A
J Oncol Pharm Pract; 2016 Jun; 22(3):561-5. PubMed ID: 25956420
[No Abstract] [Full Text] [Related]
77. The Authors Respond.
Hansen RN; Hackshaw MD; Sullivan SD; Ramsey SD
J Manag Care Spec Pharm; 2015 Sep; 21(9):844. PubMed ID: 26536677
[No Abstract] [Full Text] [Related]
78. Words of wisdom: Re: Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
Sun M; Trinh QD; Perrotte P; Karakiewicz PI
Eur Urol; 2014 May; 65(5):1014-5. PubMed ID: 24646500
[No Abstract] [Full Text] [Related]
79. Words of wisdom: Re: Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
Ouzaid I; Rini B
Eur Urol; 2014 Mar; 65(3):667-8. PubMed ID: 24484761
[No Abstract] [Full Text] [Related]
80. The Authors Respond.
Delea TE; Amdahl J; Diaz J; Nakhaipour HR; El Khoury MH
J Manag Care Spec Pharm; 2015 Sep; 21(9):836-40. PubMed ID: 26536676
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]